Ignite Creation Date:
2025-12-26 @ 10:18 PM
Ignite Modification Date:
2026-02-25 @ 3:10 AM
Study NCT ID:
NCT02124512
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2014-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Blood Lipopolysaccharide (LPS) Rifaximin Study
Sponsor:
Philip Kern
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
14-0136-F1V
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |